Center for American Progress September 17, 2020
Maura Calsyn and Thomas Waldrop

Introduction and summary

Lowering prescription drug prices continues to be a top health care priority for Americans.1 The American people want the government to take significant, meaningful actions to lower the prices of prescription drugs, and the coronavirus pandemic has further underscored the importance of ensuring that essential medicines are priced affordably—for both the health care system and individuals. As a number of treatments for the virus have emerged and clinical trials for COVID-19 vaccines continue to advance, there is a growing danger that these lifesaving treatments could have price tags that put them out of reach for millions of Americans.2

Action to lower the prices of prescription drugs is also an issue of health equity. Black Americans...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Insurance, Patient / Consumer, Pharma / Biotech, Precision Medicine, Pricing / Spending, Provider
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article